There can be no argument. RenovoRx, Inc. (NASDAQ: RNXT) shares are in rally mode, surging by over 92% since February. And on a YTD basis, the gains are more impressive, scoring an over 117% increase at press time on Wednesday and posting a new intraday 52-week high in the process*. (*share price of $5.10 on 03/01/23, […]
DelveInsight’s, “Thyroid Cancer Pipeline Insight 2023” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Thyroid Cancer pipeline landscape. It covers the Thyroid Cancer pipeline drug profiles, including Thyroid Cancer clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule […]
DelveInsight’s, “Kaposi’s Sarcoma Pipeline Insight, 2023,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Kaposi’s Sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive […]
DelveInsight’s, “Liposarcoma Pipeline Insight 2023,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Liposarcoma pipeline landscape. It covers the Liposarcoma pipeline drug profiles, including Liposarcoma clinical trials and nonclinical stage products. It also covers the Liposarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further […]
DelveInsight’s, “Retinal Vein Occlusion Pipeline Insight, 2023,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further […]
DelveInsight’s, “Esophageal Cancer Pipeline Insight, 2023” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Esophageal Cancer pipeline landscape. It covers the Esophageal Cancer pipeline drug profiles, including Esophageal Cancer clinical trials and nonclinical stage products. It also covers the Esophageal Cancer pipeline therapeutics assessment by product type, stage, route of […]
As per DelveInsight’s assessment, about 250+ key pharma and biotech companies are working on 300+ pipeline drugs in the Gene therapy Competitive landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in […]
DelveInsight Business Research LLP As per DelveInsight’s assessment, about 40+ key pharma and biotech companies are working on 45+ pipeline drugs in the Janus kinase (JAK) inhibitors Competitive landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]
Delveinsight Business Research LLP As per DelveInsight, the Attention Deficit/Hyperactivity Disorder (ADHD) Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases and the launch of better treatment options in the market. There is a significant need for non-stimulant ADHD treatments in the marketplace, especially in […]
Alzheimer’s Disease Market The Alzheimer’s Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alzheimer’s Disease pipeline products will significantly revolutionize the Alzheimer’s Disease market dynamics. DelveInsight’s “Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alzheimer’s […]
